NDC 43742-0736

Virus Plus

Influenzinum (2015-2016), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode

Virus Plus is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Deseret Biologicals, Inc.. The primary component is Influenza A Virus A/brisbane/10/2010 (h1n1) Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated); Influenza A Virus A/brisbane/10/2010 (h1n1) Neuraminidase Antigen (mdck Cell Derived, Propiolactone Inactivated); Influenza A Virus A/south Australia/55/2014 (h3n2) Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated); Influenza A Virus A/south Australia/55/2014 (h3n2) Neuraminidase Antigen (mdck Cell Derived, Propiolactone Inactivated); Influenza B Virus B/utah/9/2014 Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated); Influenza B Virus B/utah/9/2014 Neuraminidase Antigen (mdck Cell Derived, Propiolactone Inactivated); Human Adenovirus E Serotype 4; Human Adenovirus B Serotype 7; Human Herpesvirus 1; Human Herpesvirus 2; Human Herpesvirus 5; Human Herpesvirus 4; Hepatitis B Virus; Norwalk Virus.

• Product ID: 43742-0736_2aa3434c-01b8-4283-aafc-2e85abc82369
• NDC: 43742-0736
• Product Type: Human Otc Drug
• Proprietary Name: Virus Plus
• Generic Name: Influenzinum (2015-2016), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode
• Dosage Form: Liquid
• Route of Administration: ORAL
• Marketing Start Date: 2016-04-22
• Marketing End Date: 2021-06-01
• Marketing Category: UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
• Labeler Name: Deseret Biologicals, Inc.
• Substance Name: INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 (H3N2) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 (H3N2) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/UTAH/9/2014 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/UTAH/9/2014 NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); HUMAN ADENOVIRUS E SEROTYPE 4; HUMAN ADENOVIRUS B SEROTYPE 7; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 4; HEPATITIS B VIRUS; NORWALK VIRUS
• Active Ingredient Strength: 12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL
• NDC Exclude Flag: N

Packaging

NDC 43742-0736-1

30 mL in 1 BOTTLE, DROPPER (43742-0736-1)

• Marketing Start Date: 2016-04-22
• Marketing End Date: 2021-06-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 43742-0736-1 [43742073601]

Virus Plus LIQUID

• Marketing Category: unapproved homeopathic
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2016-04-22
• Marketing End Date: 2021-06-01

Drug Details

Active Ingredients

Ingredient	Strength
INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)	12 [hp_X]/mL

OpenFDA Data

• SPL SET ID: 825acc9f-a3a9-40cf-a218-7e06b3846740
• Manufacturer:
  • Deseret Biologicals, Inc.
• UNII:
  • 7COI029E6K
  • 445486QJCG
  • V3EC8AF8MF
  • 2A26YW7PNX
  • K02R887XWT
  • 22G38P19RL
  • KFL1W6W9JB
  • 77H9EM77P7
  • 9VVQ21KI5Z
  • K7O6S79496
  • 5IH4D25X1Q
  • 80T3QS071U
  • 3W5C8YUT4D
  • 74J6DNH49U

NDC Crossover Matching brand name "Virus Plus" or generic name "Influenzinum (2015-2016), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode"

NDC	Brand Name	Generic Name
43742-0397	Virus Plus	Influenzinum, Adenoviren Nosode, Herpes Simplex 1, Herpes Simplex 2, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode
43742-0539	Virus Plus	Influenzinum, Adenoviren Nosode, Herpes Simplex 1, Herpes Simplex 2, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode
43742-0559	Virus Plus	Influenzinum, Adenoviren Nosode, Herpes Simplex 1, Herpes Simplex 2, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus
43742-0736	Virus Plus	Influenzinum (2015-2016), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode
43742-0807	Virus Plus	Influenzinum (2015-2016), Adenoviren Nosode, Herpes Simplex 1, Herpes Simplex 2, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode
43742-0960	Virus Plus	Influenzinum (2016-2017), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode
43742-1117	Virus Plus	Influenzinum (2017-2018), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode
43742-1396	Virus Plus	Influenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode